|
Mar 13
|
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
|
|
Mar 12
|
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering
|
|
Mar 12
|
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities
|
|
Jun 18
|
Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
|
|
Feb 13
|
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
|
|
Nov 30
|
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023
|